Sorry, you need to enable JavaScript to visit this website.

vaccinesOur vision is to become a recognized leader in the discovery and development of innovative prophylactic and therapeutic vaccines for unmet medical needs throughout all stages of life and for all geographies and markets. We focus on Prevention of viral and bacterial infections in infants, children, adolescents and older adults; hospital acquired infections and active immune oncology (cancer vaccine) targets


We are interested in establishing alliances to pursue development of:

  • Vaccines for the prevention and/or treatment of infectious diseases
  • Vaccines for the prevention and/or treatment of non-infectious diseases with special emhasis on cancer vaccines through the active elicitation of disease-modifying immune responses

We are also interested in:

  • Adjuvants
  • Novel immune system enhancers to bolster the immune system of an older population
  • Novel in vitro systems for assessment of vaccine immunogenicity
  • Novel animal models for assessment of vaccine effectiveness
  • Novel immunomodulators of the adaptive immune response
  • Novel vaccine target antigen identification systems
  • Novel vaccine delivery platforms

Not actively seeking partnering opportunities in:

  • Novel vaccines in disease areas for which effective vaccines are already available/licensed (with the exception of novel influenza virus vaccines)